Sam Eldessouky has been named senior vice president and corporate controller, Valeant Pharmaceuticals. Mr. Eldessouky has more than 20 years of experience in accounting and finance, and joins the company from Tyco International, where he most recently served as senior vice president, controller and chief accounting officer. 
 
Mr. Eldessouky will be responsible for directing global accounting and financial reporting activities to ensure accurate and timely compliance with all internal and external requirements, and will drive efficiencies and standardization throughout the global accounting function. Mr. Eldessouky will report to Valeant’s chief financial officer, Robert Rosiello.
 
“Sam is an experienced professional with a proven track record of delivering results in a complex, global public company, and we’re pleased to have him lead Valeant’s financial reporting efforts going forward,” said Robert Rosiello, executive vice president and chief financial officer. 
 
At Tyco, Mr. Eldessouky was responsible for overseeing the finance shared services functions, external reporting, technical accounting, operational controllership, valuation and M&A accounting, treasury accounting, global consolidation, internal controls, accounting policy and training programs. During his tenure, he led the efforts to redesign the controller’s organization and the implementation of Enterprise Performance Management framework.